© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
A decade of aging brings on heart and kidney troubles in people with HIV.
A study finds that CD4 cells decline after people with HIV contract hepatitis C.
A look at 2009 to 2014 data found that those in care for HIV saw a considerable fall in treatment deferrals.
Treatment efficacy has steadily improved since effective combination HIV therapy first entered advanced clinical trials in the mid-1990s.
For over 30 years, the California-based group fought for treatments, research, education and quality health care.
Fostemsavir offers HIV treatment hope to those with no other options.
Periodic infusions of long-acting HIV antibodies may eventually become a new way of treating the virus.
December 2018 Survey
NMAC offers support and engagement opportunities to advocates living with HIV who are 50 and over.
Promising findings from a study of a two-drug injectable treatment given every four weeks.
Aprende más sobre la prevención y el tratamiento del VIH para mantenerse saludable.
“This is life or death. This is unacceptable.”
April/May 2018 Survey
People living with HIV are at greater risk for cardiovascular disease.
Overcoming the challenges of fighting HIV among Native Americans
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
